These observations are consistent with a recent study using data from the UK Biobank (n = 202, including 106 APOE4 carriers), showing that APOE4 homozygosity was related to greater informant-reported sleep disturbances when controlling for multiple demographic variables such as age, gender, depression, anxiety, and cognitive impairment [55]. The gene discussed is APOE; the disease is depressive disorder.